Your product is now available from Integrated DNA Technologies.
Many of the Swift products you have grown to love are now part of our new complete portfolio, xGen™ NGS. Through this new partnership we are pleased to offer you comprehensive next generation sequencing solutions.
xGen NGS—made for you.
Unsure of what products are available? Or, perhaps you’d like guidance on which products are compatible? If so, try our xGen NGS Solutions Builder Tool today.
Welcome to the IDT family!
Find Archer now at IDT!
All Archer information is now available on IDT’s website. You can view Archer assays alongside IDT’s xGen™ NGS portfolio to find the best next generation sequencing solution for your lab.
Confidently detect more with Archer NGS assay solutions for your solid tumor, blood cancer, immune profiling, and genetic disease research.
Choose your region, country/territory, and preferred language
(Test Only) Increasing Testing Capacity for COVID-19 with Sherlock CRISPR-Based Diagnostics
Thanks! We received your information and one of our specialists will contact you within the next 2 business days.
CRISPR-based diagnostic methods are poised to have a significant impact on global health, and now, with the first FDA-emergency authorized use of CRISPR technology, this impact is being brought directly to the fight against the global COVID-19 pandemic. Join us to learn more about how Sherlock Biosciences has been driving CRISPR innovation and how that mission, with IDT's support, has led to the Sherlock™ CRISPR SARS-CoV-2 kit. Our speakers will provide an overview of SHERLOCK CRISPR technology and how it has been adapted for specific and sensitive detection of SARS-CoV-2 to increase testing capacity.
Processing
